logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Gibbs, Wayne
    Clinical Research born in September 1958
    Individual (2 offsprings)
    Officer
    2015-09-02 ~ now
    OF - Director → CIF 0
    Mr Wayne Gibbs
    Born in September 1958
    Individual (2 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

CURA CLINICAL RESEARCH LIMITED

Period: 2015-09-02 ~ 2018-11-26
Company number: 09757746
Registered name
CURA CLINICAL RESEARCH LIMITED - Dissolved
Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Par Value of Share
Class 1 ordinary share
1 GBP2015-09-02 ~ 2016-09-30
Nominal value of shares issued
Class 1 ordinary share
1 GBP2015-09-02 ~ 2016-09-30
Tangible fixed assets
1,460 GBP2016-09-30
Debtors
12,169 GBP2016-09-30
Cash at bank and in hand
60,827 GBP2016-09-30
Current Assets
72,996 GBP2016-09-30
Current liabilities
21,753 GBP2016-09-30
Net Current Assets/Liabilities
51,243 GBP2016-09-30
Total Assets Less Current Liabilities
52,703 GBP2016-09-30
Called-up share capital
1 GBP2016-09-30
Retained earnings
52,702 GBP2016-09-30
Shareholder's fund
52,703 GBP2016-09-30
Cost/valuation of tangible fixed assets
2,062 GBP2016-09-30
Depreciation expense of tangible fixed assets in the period
602 GBP2015-09-02 ~ 2016-09-30
Depreciation of tangible fixed assets
602 GBP2016-09-30
Number of shares allotted
Class 1 ordinary share
1 shares2016-09-30
Paid-up share capital
Class 1 ordinary share
1 GBP2016-09-30
Number of shares issued
Class 1 ordinary share
1 shares2015-09-02 ~ 2016-09-30

  • CURA CLINICAL RESEARCH LIMITED
    Info
    Registered number 09757746
    Sfp 9 Ensign House, Admirals Way, Marsh Wall, London E14 9XQ
    PRIVATE LIMITED COMPANY incorporated on 2015-09-02 and dissolved on 2018-11-26 (3 years 2 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 March 2026 and licensed under the Open Government Licence v3.0.